Skip to main content
Log in

Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas

  • RESEARCH NOTE
  • Published:
Journal of Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  • Alvarez C., Tredwell S., De Vera M. and Hayden M. 2006 The genotype-phenotype correlation of hereditary multiple exostoses. Clin. Genet. 70, 122–130.

    Article  CAS  PubMed  Google Scholar 

  • Bellaiche Y., The I. and Perrimon N. 1998 Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 394, 85–88.

    Article  CAS  PubMed  Google Scholar 

  • Bovee J. V., Cleton-Jansen A. M., Wuyts W., Caethoven G., Taminiau A. H., Bakker E. et al. 1999 EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am. J. Hum. Genet. 65, 689–698.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Francannet C., Cohen-Tanugi A., Le Merrer M., Munnich A., Bonaventure J. and Legeai-Mallet L. 2001 Genotype-phenotype correlation in hereditary multiple exostoses. J. Med. Genet. 38, 430–434.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gu W., Zhang F. and Lupski J. R. 2008 Mechanisms for human genomic rearrangements. Pathogenetics 1, 4.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hameetman L., Szuhai K., Yavas A., Knijnenburg J., Van Duin M., Van Dekken H. et al. 2007 The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J. Natl. Cancer Inst. 99, 396–406.

    Article  CAS  PubMed  Google Scholar 

  • Hecht J. T., Hogue D., Wang Y., Blanton S. H., Wagner M., Strong L. C. et al. 1997 Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am. J. Hum. Genet. 60, 80–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hennekam R. C. 1991 Hereditary multiple exostoses. J. Med. Genet. 28, 262–266.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jennes I., De Jong D., Mees K., Hogendoorn P. C., Szuhai K. and Wuyts W. 2011 Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families. BMC Med. Genet. 12, 85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jennes I., Entius M. M., Van Hul E., Parra A., Sangiorgi L. and Wuyts W. 2008 Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. J. Mol. Diagn. 10, 85–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jennes I., Pedrini E., Zuntini M., Mordenti M., Balkassmi S., Asteggiano C. G. et al. 2009 Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum. Mutat. 30, 1620–1627.

    Article  CAS  PubMed  Google Scholar 

  • Legeai-Mallet L., Munnich A., Maroteaux P. and Le Merrer M. 1997 Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin. Genet. 52, 12–16.

    Article  CAS  PubMed  Google Scholar 

  • McCormick C., Leduc Y., Martindale D., Mattison K., Esford L. E., Dyer A. P. et al. 1998 The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19, 158–161.

    Article  CAS  PubMed  Google Scholar 

  • McCormick C., Duncan G., Goutsos K. T. and Tufaro F. 2000 The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc. Natl. Acad. Sci. USA. 97, 668–673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park K. J., Shin K. H., Ku J. L., Cho T. J., Lee S. H., Choi I. H. et al. 1999 Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses. J. Hum. Genet. 44, 230–234.

    Article  CAS  PubMed  Google Scholar 

  • Pedrini E., Jennes I., Tremosini M., Milanesi A., Mordenti M., Parra A. et al. 2011 Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of “protective” and “risk” factors. J. Bone Joint Surg. Am. 93, 2294–2302.

    Article  PubMed  Google Scholar 

  • Porter D. E., Lonie L., Fraser M., Dobson-Stone C., Porter J. R., Monaco A. P. et al. 2004 Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J. Bone Joint Surg. Br. 86, 1041–1046.

    Article  CAS  PubMed  Google Scholar 

  • Sarrion P., Sangorrin A., Urreizti R., Delgado A., Artuch R., Martorell L. et al. 2013 Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas. Sci. Rep. 3, 1346.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seki H., Kubota T., Ikegawa S., Haga N., Fujioka F., Ohzeki S. et al. 2001 Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses. Am. J. Med. Genet. 99, 59–62.

    Article  CAS  PubMed  Google Scholar 

  • Szuhai K., Jennes I., De Jong D., Bovee J. V., Wiweger M., Wuyts W. et al. 2011 Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum. Mutat. 32, E2036–E2049.

    Article  CAS  PubMed  Google Scholar 

  • Vink G. R., White S. J., Gabelic S., Hogendoorn P. C., Breuning M. H. and Bakker E. 2005 Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations. Eur. J. Hum. Genet. 13, 470–474.

    Article  CAS  PubMed  Google Scholar 

  • Vujic M., Bergman A., Romanus B., Wahlstrom J. and Martinsson T. 2004 Hereditary multiple and isolated sporadic exostoses in the same kindred: identification of the causative gene (EXT2) and detection of a new mutation, nt112delAT, that distinguishes the two phenotypes. Int. J. Mol. Med. 13, 47–52.

    CAS  PubMed  Google Scholar 

  • Wuyts W., Schmale G. A., Chansky H. A. and Raskind W. H. 1993 Hereditary multiple osteochondromas. In Gene reviews (ed. R. A. Pagon, M. P. Adam, H. H. Ardinger, T. D. Bird, C. R. Dolan, C. T. Fong, R. J. H. Smith and K. Stephens). University of Washington, Seattle.

  • Xu L., Xia J., Jiang H., Zhou J., Li H., Wang D. et al. 1999 Mutation analysis of hereditary multiple exostoses in the Chinese. Hum. Genet. 105, 45–50.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the patients and their families.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to GEORGE A. TANTELES.

Additional information

[Tanteles G. A., Nicolaou M., Neocleous V., Shammas C., Loizidou M. A., Alexandrou A., Ellina E., Patsia N., Sismani C., Phylactou L. A. and Christophidou-Anastasiadou V. 2015 Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas. J. Genet. 94, xx–xx]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TANTELES, G.A., NICOLAOU, M., NEOCLEOUS, V. et al. Genetic screening of EXT1 and EXT2 in Cypriot families with hereditary multiple osteochondromas. J Genet 94, 749–754 (2015). https://doi.org/10.1007/s12041-015-0564-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-015-0564-3

Keywords

Navigation